Ibrutinib hard capsule for oral use, Ibrutinib
PCYC-1141-CA
Phase 3 small_molecule active
Quick answer
Ibrutinib hard capsule for oral use, Ibrutinib for Follicular Lymphoma is a Phase 3 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie Deutschland GmbH & Co. KG
- Indication
- Follicular Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active